Piramal Pharma Limited: board meetings

17 records, the earliest from 8 Nov 2022. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

17 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DatePurposeNotes
29 Jul 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
28 Apr 2026Financial ResultsTo consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for quarter and financial year ended 31st March, 2026.
28 Jan 2026Financial ResultsBoard Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31st December, 2025.
5 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
28 Jul 2025Financial ResultsIntimation as per Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
14 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
28 Jan 2025Financial ResultsTo consider and approve the financial results for the period ended December 31, 2024
23 Oct 2024Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024
26 Jul 2024Financial ResultsTo consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the period ended June 30, 2024
10 May 2024Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.